فهرست مطالب mahyar zaman

The goal of the present study was to design a registration system for recording suicide in Iran، capable of designing identification pathways، registration، and report and follow-up of suicide cases and deaths due to suicide.

Through library assessments and surveying suicide registration systems in other countries (Denmark، India and WHO)، potential methods of suicide in Iran were identified; also، potential methods of identifying suicide cases in the country were designed and finalized subsequent to group consultation.

Suicide registration forms were designed، using the collected data. In this system: 1- The Health and Treatment Network is considered to be the appropriate site for the collection of data related to suicide، 2- Instances of suicide deaths and suicide attempts will be completely registered، 3- Data will be gathered from treatment centers and other contributing centers in general monthly forms، 4- Mental health attendants will enter the data into the computer system each month، in the suicide registration center affiliated to the health and treatment center، 5- The system will be primarily executed in two universities، 6- Training of target group (managers and personnel) in the primary stages of execution is important.

The launch of the system for recording suicidal behavior in the country is the first essential step in the control and prevention of suicide.

Hypertension (HTN) is one of the most important problems in all parts of the world. Although the disease is usually asymptomatic, its diagnosis and treatment are easy. The aim of this study was to compare the effect of Nifedipine (Adalat®), Captopril and sublingual Nitroglycerin on reducing blood pressure (BP). This study was a parallel group randomized controlled trial. From the patients referred to our heart clinic, 120 patients with severe HTN were enrolled in the study. The patients were randomly allocated into 3 groups A, B, and C. The patients were advised to use 5 drops of Adalat in group A, Captopril 25 mg sublingually in group B, and 1 sublingual Nitroglycerin pearl in group C. The BP was measured every 20 minutes during one hour. Systolic BP was reduced significantly by Adalat and Captopril compared with sublingual Nitroglycerin in the 20th, 40th and 60th minutes (P= 0.001), but there was no significant difference between Adalat and captopril in reducing systolic BP. In addition, the result of reducing diastolic BP was not significantly different among the three groups. We saw the same effect on reducing BP by Captopril, Adalat, and sublingual Nitroglycerin. Among these three drugs, the side effects of Captopril were the least frequent. Adalat caused headache and flushing. Thus, it seems Captopril can be used instead of Adalat in medical centers.

Hyperbilirubinemia is a common and usually a benign problem of neonates that affect on 80% immature and 60% term of them. Oral administration of nonabsorbable substances that bind to bilirubin in the intestinal lumen and reduce enteric absorption of bilirubin may reduce peak serum bilirubin. Activated charcoal, agar and cholestramin have been used but further study of this type of therapy is needs. In this study we assess efficacy of oral Taranjabin (mann), one of the traditional treatment in our area, in neonatal hyperbilirubinemia. This clinical trial study was conducted in 86 neonates (41 and 45 newborns respectively in case and control groups). Subjects were selected among full term neonates whose weight were over 2500 gram and non of them suffered from any risk factor such as hemolysis, sepsis etc. case group (41 neonates) received oral suspension 30gr of Taranjabin 1 cc/kg q12hr pluses phototherapy and control group put under phototherapy alone. Blood sample were taken from them before treatment and once every 24 hours. Data were analyzed by SPSS variance test and T-test software. Results showed that there were no significant between two groups in total bilirubin level in the first and second day after Taranjabin administration and in hospitalization period in both groups (p=0.04%). The efficacy of phototherapy in decreasing the serum bilirubin in neonatal jaundice cannot be augmented by oral Taranjabin, on the contrary of peoples’ belief.

Disseminated bacilli calmette-Guerin (BCG) infection after inoculation with live vaccine is considered to result from impaired immunity of the child. However, half of the cases are regarded as idiopathic because no well-defined immunodeficiency condition can account for the infection. Case report: An 8-month-old male infant was admitted with an ulcer on his left arm at the site of a BCG inoculation received five mounths previously. He also had a fever, productive cough and respiratory distress for two weeks prior to admission and the patient received a broad–spectrum antibiotic without any response. A clinical examination revealed a 3×3 cm mass in the upper, left quadrant of the patient’s chest. A chest X-ray showed widespread reticulation and corrosion on the seventh rib. The patient died from cardiopulmonary arrest 12 days post admission. In the antopsy of the patient, samples taken from several organs of he body showed a collection of acid–fast bacilli and a spread of tuberculoid infection (BCGosis). Although the BCG vaccine has been in use since 1921 and its protective effect for disseminated, meningial and pulmonary tuberculosis is clear, controversy continues around its use. The most serious complication of BCG vaccine is a disseminated BCG infection that may lead to death.